186 related articles for article (PubMed ID: 33688396)
1. Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2.
Dennis AG; Almaguer-Mederos LE; Raúl RA; Roberto RL; Luis VP; Dany CA; Yanetza GZ; Yaimeé VM; Annelié ED; Arnoy PA; Reydenis TV
Oxid Med Cell Longev; 2021; 2021():9875639. PubMed ID: 33688396
[TBL] [Abstract][Full Text] [Related]
2. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
3. Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype.
Almaguer-Gotay D; Almaguer-Mederos LE; Aguilera-Rodríguez R; Estupiñán-Rodríguez A; González-Zaldivar Y; Cuello-Almarales D; Laffita-Mesa JM; Vázquez-Mojena Y
J Neurol Sci; 2014 Jun; 341(1-2):41-5. PubMed ID: 24780439
[TBL] [Abstract][Full Text] [Related]
4. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
5. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
6. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2.
Almaguer-Mederos LE; Almaguer-Gotay D; Aguilera-Rodríguez R; González-Zaldívar Y; Cuello-Almarales D; Laffita-Mesa J; Vázquez-Mojena Y; Zayas-Feria P; Rodríguez-Labrada R; Velázquez-Pérez L; MacLeod P
J Neurol Sci; 2017 Jan; 372():324-328. PubMed ID: 28017238
[TBL] [Abstract][Full Text] [Related]
7. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
[TBL] [Abstract][Full Text] [Related]
8. Spinocerebellar Ataxia Type 2.
Scoles DR; Pulst SM
Adv Exp Med Biol; 2018; 1049():175-195. PubMed ID: 29427103
[TBL] [Abstract][Full Text] [Related]
9. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
Almaguer-Mederos LE; Aguilera-Rodríguez R; Almaguer-Gotay D; Hechavarría-Barzaga K; Álvarez-Sosa A; Chapman-Rodríguez Y; Silva-Ricardo Y; González-Zaldivar Y; Vázquez-Mojena Y; Cuello-Almarales D; Rodríguez-Estupiñán A
Cerebellum; 2020 Aug; 19(4):597-604. PubMed ID: 32440846
[TBL] [Abstract][Full Text] [Related]
12. Buccal Cell Micronucleus Frequency Is Significantly Elevated in Patients with Spinocerebellar Ataxia Type 2.
Cuello-Almarales DA; Almaguer-Mederos LE; Vázquez-Mojena Y; Almaguer-Gotay D; Zayas-Feria P; Laffita-Mesa JM; González-Zaldívar Y; Aguilera-Rodríguez R; Rodríguez-Estupiñán A; Velázquez-Pérez L
Arch Med Res; 2017 Apr; 48(3):297-302. PubMed ID: 28923333
[TBL] [Abstract][Full Text] [Related]
13. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
[TBL] [Abstract][Full Text] [Related]
14. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous ALS and SCA2 associated with an intermediate-length
Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
[TBL] [Abstract][Full Text] [Related]
16. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
17. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals.
Inagaki A; Iida A; Matsubara M; Inagaki H
Eur J Neurol; 2005 Sep; 12(9):725-8. PubMed ID: 16128876
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.
Laffita-Mesa JM; Bauer PO; Kourí V; Peña Serrano L; Roskams J; Almaguer Gotay D; Montes Brown JC; Martínez Rodríguez PA; González-Zaldívar Y; Almaguer Mederos L; Cuello-Almarales D; Aguiar Santiago J
Hum Genet; 2012 Apr; 131(4):625-38. PubMed ID: 22037902
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic analysis of spinocerebellar ataxia in Mali.
Traoré M; Coulibaly T; Meilleur KG; La Pean A; Sangaré M; Landouré G; Mochel F; Karambé M; Guinto CO; Fischbeck KH
Eur J Neurol; 2011 Oct; 18(10):1269-71. PubMed ID: 21418439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
